Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as Adjuvant to Peribulbar Block in Retinal Surgery
NCT02282787Phase 3Unknown
- Sponsor
- King Saud University
- Start
- Jan 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine (2 arms), sponsored by King Saud University. Primary endpoints: Onset of the motor and sensory block and Duration of the motor and sensory block. Status: unknown.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT02282787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02282787.